These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4006031)

  • 1. Structure and synthesis of WB-3559 A, B, C and D, new fibrinolytic agents isolated from Flavobacterium sp.
    Uchida I; Yoshida K; Kawai Y; Takase S; Itoh Y; Tanaka H; Kohsaka M; Imanaka H
    Chem Pharm Bull (Tokyo); 1985 Jan; 33(1):424-7. PubMed ID: 4006031
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on WB-3559 A, B, C and D, new potent fibrinolytic agents. II. Structure elucidation and synthesis.
    Uchida I; Yoshida K; Kawai Y; Takase S; Itoh Y; Tanaka H; Kohsaka M; Imanaka H
    J Antibiot (Tokyo); 1985 Nov; 38(11):1476-86. PubMed ID: 4077727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on WB-3559 A, B, C and D, new potent fibrinolytic agents. I. Discovery, identification, isolation and characterization.
    Yoshida K; Iwami M; Umehara Y; Nishikawa M; Uchida I; Kohsaka M; Aoki H; Imanaka H
    J Antibiot (Tokyo); 1985 Nov; 38(11):1469-75. PubMed ID: 4077726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of dipeptides containing S-hexylcysteine.
    Bruzgo I; Midura-Nowaczek K
    Acta Pol Pharm; 2007; 64(5):479-82. PubMed ID: 18540170
    [No Abstract]   [Full Text] [Related]  

  • 5. [A new metabolite with fungistatic and bacteriostatic activity, produced by strain L-30 of Flavobacterium sp].
    Shenin IuD; Kruglikova LF; Vasiuk LF; Kozhemiakov AP; Chebotar' VK; Popova TA
    Antibiot Khimioter; 1996 May; 41(5):6-12. PubMed ID: 9054320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design of highly potent noncovalent thrombin inhibitors that utilize a novel lipophilic binding pocket in the thrombin active site.
    Tucker TJ; Lumma WC; Mulichak AM; Chen Z; Naylor-Olsen AM; Lewis SD; Lucas R; Freidinger RM; Kuo LC
    J Med Chem; 1997 Mar; 40(6):830-2. PubMed ID: 9083470
    [No Abstract]   [Full Text] [Related]  

  • 7. A soil Flavobacterium sp. that degrades sulphanilamide and asulam.
    Walker N
    J Appl Bacteriol; 1978 Aug; 45(1):125-9. PubMed ID: 701200
    [No Abstract]   [Full Text] [Related]  

  • 8. Chemical and molecular characterization of metabolites from Flavobacterium sp.
    Enisoglu-Atalay V; Atasever-Arslan B; Yaman B; Cebecioglu R; Kul A; Ozilhan S; Ozen F; Catal T
    PLoS One; 2018; 13(10):e0205817. PubMed ID: 30332474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of a new plasmid from a Flavobacterium sp. which carries the genes for degradation of 2,4-dichlorophenoxyacetate.
    Chaudhry GR; Huang GH
    J Bacteriol; 1988 Sep; 170(9):3897-902. PubMed ID: 2842290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Flavobacterium sp. that degrades diazinon and parathion.
    Sethunathan N; Yoshida T
    Can J Microbiol; 1973 Jul; 19(7):873-5. PubMed ID: 4727806
    [No Abstract]   [Full Text] [Related]  

  • 11. Isolation of chitinovorin D.
    Shoji J; Sakazaki R; Kato T; Terui Y; Matsumoto K; Tanimoto T; Hattori T; Hirooka K; Kondo E
    J Antibiot (Tokyo); 1985 Apr; 38(4):538-40. PubMed ID: 3839232
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential antiarrhythmic agents. II. Antiarrhythmic activity of basic N-(substituted phenyl and benzyl)dipeptides.
    Lindberg UH; Akerman B
    Acta Pharm Suec; 1985; 22(6):321-34. PubMed ID: 3832783
    [No Abstract]   [Full Text] [Related]  

  • 13. Flavobacterium rivuli sp. nov., Flavobacterium subsaxonicum sp. nov., Flavobacterium swingsii sp. nov. and Flavobacterium reichenbachii sp. nov., isolated from a hard water rivulet.
    Ali Z; Cousin S; Frühling A; Brambilla E; Schumann P; Yang Y; Stackebrandt E
    Int J Syst Evol Microbiol; 2009 Oct; 59(Pt 10):2610-7. PubMed ID: 19622646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of new class dipeptide analogues with improved permeability and antithrombotic activity.
    Zhao M; Bi L; Bi W; Wang C; Yang Z; Ju J; Peng S
    Bioorg Med Chem; 2006 Jul; 14(14):4761-74. PubMed ID: 16616499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthesis of carbonyl-bisamino acid derivatives as potential ACE inhibitors].
    Henklein P; Böttcher M; Heder G; Siems WE; Niedrich H
    Pharmazie; 1986 Jan; 41(1):56-7. PubMed ID: 3008196
    [No Abstract]   [Full Text] [Related]  

  • 16. Catabolism of pentachlorophenol by a Flavobacterium sp.
    Steiert JG; Crawford RL
    Biochem Biophys Res Commun; 1986 Dec; 141(2):825-30. PubMed ID: 3801030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of alkylamides of dipeptides as potential plasmin inhibitors.
    Midura-Nowaczek K; Lepietuszko I; Bruzgo I
    Acta Pol Pharm; 2006; 63(1):33-7. PubMed ID: 17515327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologically active halophthaloylpeptides. I. Synthesis of tetrachlorophthaloylamino acids and dipeptide derivatives.
    el-Naggar AM; Zaher MR; el-Basiouny M; Khalaf NS
    Farmaco Sci; 1984 Feb; 39(2):154-61. PubMed ID: 6714410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of metalloendopeptidases by 2-mercaptoacetyl-dipeptides.
    Blumberg S; Tauber Z
    Eur J Biochem; 1983 Oct; 136(1):151-4. PubMed ID: 6413206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and antithrombotic activities of 6-(substituted phenyl)-5-hydroxymethyl-4,5-dihydro-3(2H)pyridazinones.
    Barlocco D; Martini A; Pinna GA; Curzu MM; Sala F; Germini M
    Farmaco Sci; 1987 Aug; 42(8):585-94. PubMed ID: 3666129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.